Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Lycanbull Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1825866616254480384.png) Lycanbull [@Lycanbull](/creator/twitter/Lycanbull) on x 4980 followers
Created: 2025-07-18 10:59:20 UTC

$BMY Bristol Myers Squibb Announces Topline Results from Phase X INDEPENDENCE Trial for Reblozyl® (luspatercept-aamt) in Adult Patients with Myelofibrosis-Associated Anemia


![](https://pbs.twimg.com/card_img/1945800532867596289/tWjDCExI?format=png&name=600x314)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946162866593075589/c:line.svg)

**Related Topics**
[$bmy](/topic/$bmy)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/Lycanbull/status/1946162866593075589)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Lycanbull Avatar Lycanbull @Lycanbull on x 4980 followers Created: 2025-07-18 10:59:20 UTC

$BMY Bristol Myers Squibb Announces Topline Results from Phase X INDEPENDENCE Trial for Reblozyl® (luspatercept-aamt) in Adult Patients with Myelofibrosis-Associated Anemia

XXX engagements

Engagements Line Chart

Related Topics $bmy stocks healthcare

Post Link

post/tweet::1946162866593075589
/post/tweet::1946162866593075589